Hosted on MSN9d
Orphelia explores avenues for liquid neuroblastoma med after EU CHMP rejection
However, after a re-evaluation on 27 February 2025, the CHMP upheld its initial stance, stating that the committee’s concerns ...
manilatimes2d
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use ...